Contineum Therapeutics, Inc. (CTNM)
Pharmaceutical Preparations
Latest Price
$15.49
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
6.70
P/B Ratio
2.31
Institutional Ownership
80.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2.84M | $37.0M | 7.61% | -- | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 2.73M | $35.0M | 7.32% | +285.9K | 2026-03-31 |
| JOHNSON & JOHNSON | 1.98M | $25.0M | 5.30% | -- | 2026-03-31 |
| FRANKLIN RESOURCES INC | 1.84M | $24.0M | 4.93% | -40.1K | 2026-03-31 |
| Balyasny Asset Management L.P. | 1.69M | $22.0M | 4.51% | -157.2K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 1.54M | $20.0M | 4.11% | +704.8K | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 1.42M | $18.0M | 3.81% | -- | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 1.30M | $16.0M | 3.47% | -883.7K | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 1.26M | $16.0M | 3.36% | -209.0K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.21M | $15.0M | 3.25% | -- | 2026-03-31 |